H5N1 Vaccine Study in Japanese Adults (NCT01382329) | Clinical Trial Compass
CompletedPhase 2/3
H5N1 Vaccine Study in Japanese Adults
Japan340 participantsStarted 2011-06
Plain-language summary
The purpose of this study is to obtain immunogenicity and safety data of two different dose levels of an H5N1 pandemic influenza vaccine in a healthy Japanese adult population aged 18 to 59 years.
Who can participate
Age range18 Years – 59 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.